Rosix Combi 5 mg/10 mg tablete
| Name | Rosix Combi 5 mg/10 mg tablete |
|---|---|
| Former Name | Ezehron Duo 5 mg/10 mg tablete |
| Marketing Authorisation Number | HR-H-191795318 |
| Active Substance | rosuvastatinkalcij ezetimib |
| Composition | svaka tableta sadrži 5 mg rosuvastatina (u obliku rosuvastatinkalcija) i 10 mg ezetimiba |
| Pharmaceutical Form | tableta |
| Manufacturer | Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder | Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date | 24.08.2018 |
| MA Period of Validity | 10.05.2023 |
| Classification Number | UP/I-530-09/16-01/261 |
| Registration Number | 381-12-01/14-18-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C10BA06 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
